---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-247545"
form_type: "8-K"
ticker: "CNMD"
cik: "0000816956"
company_name: "CONMED Corp"
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:43:01.434505+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# CONMED Q3 2024: adj. EPS $1.05 beats; revenue guidance trimmed; CEO transition to Beyer Jan 2025

## Summary
- Sales $316.7M (+4.0% YoY); GAAP EPS $1.57 (vs $0.50); adjusted EPS $1.05 (+16.7%).
- Full-year revenue guidance lowered to $1.300–1.305B from $1.305–1.315B; adj. EPS raised to $4.00–4.05 from $3.95–4.02.
- COO Pat Beyer appointed President and CEO effective Jan 1, 2025; Curt Hartman will retire and serve as Special Advisor through March 2027.
- Hartman to receive consulting fee of $1.936M plus 2x avg bonus; equity vesting continues through separation date.
- Domestic sales +7.4% YoY; international -0.4%; single-use products +6.9%, capital -10.6%.

## SEC filing metadata
- accession: 0001193125-24-247545
- form_type: 8-K
- ticker: CNMD
- cik: 0000816956
- company_name: CONMED Corp
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/0001193125-24-247545-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/d905685d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-247545
- JSON: https://secwatch.observer/filing/0001193125-24-247545.json
- Plain text: https://secwatch.observer/filing/0001193125-24-247545.txt

## Key facts
- Executive change
  Curt R. Hartman changed role as Chair of the Board at CONMED Corp.
  - Action: cease
  - Role: Chair of the Board
  source text: effective as of October 31, 2024, Curt R. Hartman’s service as Chair of the Board will cease
  evidence_url: https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/0001193125-24-247545-index.htm
- Executive change
  Curt R. Hartman was appointed as Special Advisor at CONMED Corp.
  - Action: appointed
  - Role: Special Advisor
  source text: Commencing on March 3, 2025 (the 'Transition Date'), Mr. Hartman will serve as a Special Advisor
  evidence_url: https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/0001193125-24-247545-index.htm
- Executive change
  Curt R. Hartman departed as Special Advisor at CONMED Corp.
  - Action: will cease
  - Role: Special Advisor
  source text: As of the Separation Date, Mr. Hartman’s service relationship with the Company will cease.
  evidence_url: https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/0001193125-24-247545-index.htm
- Executive change
  Curt R. Hartman changed role as non-executive officer at CONMED Corp.
  - Action: transitioned
  - Role: non-executive officer
  source text: Effective as of January 1, 2025, Mr. Hartman will transition into a non-executive officer role
  evidence_url: https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/0001193125-24-247545-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.